Janice Troha is President & VP at Nivalis Therapeutics, Inc. (NVLS). They have made 1 open-market trade across 1 company since 2017, most recently 2017-05-05.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $23K since 2017, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NVLS | 10,000 | $96K |
Shares reported on the most recent Form 4, priced at the 2017-05-09 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NVLS | BUY | 2017-05-05 | 2017-05-09 | $2.34 | $23K | -1.3% | -3.4% | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.